CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy Director bought 2,000 shares at $6.95 ($13,900)
- 4 Open-market buy Director bought 2,000 shares at $6.95 ($13,900)
- 4 Open-market buy Director bought 2,000 shares at $5.66 ($11,320)
- 4 Open-market buy Director bought 2,000 shares at $5.67 ($11,340)
- 4 Open-market buy Director bought 2,000 shares at $5.66 ($11,320)
- 4 Open-market buy Director bought 2,000 shares at $5.40 ($10,800)
- 4 Open-market buy Director bought 2,000 shares at $5.40 ($10,800)
- 4 Open-market buy Beerman Noah D bought 5,000 shares at $4.99 ($24,960)
- 4 Open-market buy President and CEO bought 1,500 shares at an average $5.22 ($7,837)
- 4 Open-market buy Director bought 4,000 shares at an average $5.35 ($21,380)
- 4 Open-market buy Director bought 2,000 shares at $7.00 ($14,000)
- 4 Derivatives Options or other derivatives
Page 14 of 15 · 291 filings